Press Releases

Percheron Disappointed in Avicursen (ATL1102) Study For Duchenne (DMD)

Press Releases DMD Warrior DMD Warrior -
Percheron Therapeutics has announced that it will investigate avicursen (ATL1102) in other indications besides Duchenne muscular dystrophy (DMD) following disappointing Phase IIb results last...

Santhera Enters into Supply and Distribution Agreement for AGAMREE (Vamorolone) with Clinigen Group

Press Releases DMD Warrior DMD Warrior -
Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) in countries where...
Load more

Popular

About us

We do not want children to die from a disease that can be cured. We want to give hope to families and ensure that all children with DMD are treated and regain their health.

Latest Articles

Micro Dystrophin: 5 Critical Questions Everyone Is Thinking About

DMD 0
Micro dystrophin and full-length dystrophin play crucial roles in...

SonoThera Ultrasound-Mediated Delivery Method Can Deliver Full-Length Dystrophin to Cells

Press Releases 0
The findings of the study, which are currently being...

Scribe Therapeutics and Prevail Therapeutics to Share In Vivo CRISPR-based Genome Editing Data at ASGCT 2025

Press Releases 0
Scribe Therapeutics, a genetic medicines company unlocking the potential...

Most Popular

Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy

Approved Treatments 5
A genetic condition known as Duchenne muscular dystrophy (DMD)...

Potential Upcoming New Gene Therapies for Duchenne Muscular Dystrophy

Research 3
The results of new gene therapy studies for Duchenne...

What is Duvyzat (Givinostat)?

Approved Treatments 1
For individuals with Duchenne muscular dystrophy (DMD), adults and...

© 2024 - 2025 DMD Warrior. All rights reserved.